A 49-year-old woman presents to her primary care physician with fatigue. She reports that she has recently been sleeping more than usual and says her “arms and legs feel like lead” for most of the day. She has gained 10 pounds over the past 3 months which she attributes to eating out at restaurants frequently, particularly French cuisine. Her past medical history is notable for social anxiety disorder. She took paroxetine and escitalopram in the past but had severe nausea and headache while taking both. She has a 10 pack-year smoking history and has several glasses of wine per day. Her temperature is 98.6°F (37°C), blood pressure is 130/65 mmHg, pulse is 78/min, and respirations are 16/min. Physical examination reveals an obese woman with a dysphoric affect. She states that her mood is sad but she does experience moments of happiness when she is with her children. The physician starts the patient on a medication to help with her symptoms. Three weeks after the initiation of the medication, the patient presents to the emergency room with a severe headache and agitation. Her temperature is 102.1°F (38.9°C), blood pressure is 180/115 mmHg, pulse is 115/min, and respirations are 24/min. Which of the following is the mechanism of action of the medication that is most likely responsible for this patient’s symptoms?

Inhibition of amine degradation

Inhibition of serotonin and norepinephrine reuptake

Inhibition of the adrenergic alpha-2 receptor and serotonin-2 and -3 receptors

Inhibition of serotonin reuptake

Partial agonism of serotonin-1A receptor

A 25-year-old woman presents to her college campus clinic with the complaint of being unable to get up for her morning classes. She says that, because of this, her grades are being affected. For the past 6 weeks, she says she has been feeling depressed because her boyfriend dumped her. She finds herself very sleepy, sleeping in most mornings, eating more snacks and fast foods, and feeling drained of energy. She is comforted by her friend’s efforts to cheer her up but still feels guarded around any other boy that shows interest in her. The patient says she had similar symptoms 7 years ago for which she was prescribed several selective serotonin reuptake inhibitors (SSRIs) and a tricyclic antidepressant (TCA). However, none of the medications provided any long-term relief. She has prescribed a trial of Phenelzine to treat her symptoms. Past medical history is significant for a long-standing seizure disorder well managed with phenytoin. Which of the following statements would most likely be relevant to this patient’s new medication?

“While taking this medication, you should avoid drinking red wine.”

“This medication is known to cause anorgasmia during treatment.”

“You will have a risk for cardiotoxicity from this medication.”

“A common side effect of this medication is sedation.”

“While on this medication, you may have a decreased seizure threshold.”

A 28-year-old man is brought to the emergency department after he was found half dressed and incoherent in the middle of the road. In the emergency department he states that he has not slept for 36 hours and that he has incredible ideas that will make him a billionaire within a few months. He also states that secret agents from Russia are pursuing him and that he heard one of them speaking through the hospital intercom. His past medical history is significant only for a broken arm at age 13. On presentation, his temperature is 102.2°F (39°C), blood pressure is 139/88 mmHg, pulse is 112/min, and respirations are 17/min. Physical exam reveals pupillary dilation and psychomotor agitation. Which of the following mechanisms is most likely responsible for this patient's symptoms?

Increased biogenic amine release

N-methyl-D-aspartate receptor antagonist

Gamma-aminobutyric acid receptor agonist

A 58-year-old female presents to her primary care physician with a 1-month history of facial and chest flushing, as well as intermittent diarrhea and occasional difficulty breathing. On physical exam, a new-onset systolic ejection murmur is auscultated and is loudest at the left second intercostal space. Subsequent echocardiography reveals leaflet thickening secondary to fibrous plaque deposition on both the pulmonic and tricuspid valves. Which of the following laboratory abnormalities would most likely be found in this patient?

Elevated urinary 5-hydroxyindoleacetic acid

Elevated urinary vanillylmandelic acid

Serotonin syndrome for USMLE Step 1: High-Yield Pharmacology Lessons

Pathophysiology - Serotonin Overload

Core Defect: A functional excess of serotonin ($5-HT$) at the synaptic cleft, leading to widespread effects in the central and peripheral nervous systems.
Primary Mechanism: Intense, non-physiological stimulation of postsynaptic serotonin receptors.
- $5-HT_{2A}$ Receptors: Overactivation is strongly linked to the most severe symptoms, including neuromuscular hyperactivity (e.g., clonus, rigidity) and hyperthermia.
- $5-HT_{1A}$ Receptors: Stimulation contributes to cognitive and behavioral changes like agitation and confusion.

⭐ While multiple serotonergic agents are a classic cause, serotonin syndrome can be precipitated by a single agent, especially after a dose increase.

Causative Agents - The Usual Suspects

Increased serotonin from various sources can trigger this syndrome. Combining drugs from different classes significantly elevates the risk, especially with MAOIs.

Drug Class	Examples
SSRIs	Sertraline, Fluoxetine, Citalopram
SNRIs	Venlafaxine, Duloxetine
MAOIs	Selegiline, Phenelzine, Tranylcypromine
TCAs	Amitriptyline, Imipramine, Clomipramine
Opioids	Tramadol, Fentanyl, Meperidine
Triptans	Sumatriptan, Rizatriptan
Other	Linezolid, Dextromethorphan, St. John's Wort

Clinical Features - The Serotonin Triad

Cognitive/Mental Status Changes
- Agitation, restlessness
- Confusion, delirium
Autonomic Hyperactivity
- Fever, diaphoresis (sweating)
- Tachycardia, hypertension
- Mydriasis (dilated pupils)
Neuromuscular Excitation
- Clonus (inducible or spontaneous)
- Hyperreflexia (brisk reflexes)
- Tremor, myoclonus

⭐ Spontaneous or inducible clonus, especially in the lower extremities, is a highly specific and key diagnostic finding for serotonin syndrome.

📌 Mnemonic: SHIVERS

Shivering
Hyperreflexia
Increased temperature
Vital sign instability
Encephalopathy
Restlessness
Sweating

Diagnosis & Management - Spotting and Stopping

Diagnosis: Primarily clinical, using the Hunter Toxicity Criteria. Requires history of serotonergic agent use plus one of the following:
- Spontaneous clonus
- Inducible clonus PLUS agitation or diaphoresis
- Ocular clonus PLUS agitation or diaphoresis
- Tremor PLUS hyperreflexia
- Hypertonia PLUS temperature > 38°C

⭐ Cyproheptadine is a key antidote, but supportive care and discontinuation of the causative agent are the most critical first steps in management.

High‑Yield Points - ⚡ Biggest Takeaways

Results from excess serotonergic activity, typically from combining drugs like SSRIs with MAOIs.

Classic triad: autonomic dysfunction (hyperthermia, diaphoresis), neuromuscular hyperactivity, and altered mental status.

Hyperreflexia and clonus, especially in the lower extremities, are key diagnostic clues.

Onset is rapid, occurring within hours of a medication change.

Management requires stopping the offending agent and providing supportive care.

Cyproheptadine is the antidote for moderate-to-severe cases.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play